首页> 外文期刊>Environmental health perspectives. >Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident (1998-2000).
【24h】

Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident (1998-2000).

机译:放射碘暴露后的亚临床甲状腺功能减退症:霍诺贝利事故后(1998-2000年)的甲状腺癌和其他甲状腺疾病的乌克兰裔美国人队列研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Hypothyroidism is the most common thyroid abnormality in patients treated with high doses of iodine-131 (131I). Data on risk of hypothyroidism from low to moderate 131I thyroid doses are limited and inconsistent. OBJECTIVE: This study was conducted to quantify the risk of hypothyroidism prevalence in relation to 131I doses received because of the Chornobyl accident. METHODS: This is a cross-sectional (1998-2000) screening study of thyroid diseases in a cohort of 11,853 individuals < 18 years of age at the time of the accident, with individual thyroid radioactivity measurements taken within 2 months of the accident. We measured thyroid-stimulating hormone (TSH), free thyroxine, and antibodies to thyroid peroxidase (ATPO) in serum. RESULTS: Mean age at examination of the analysis cohort was 21.6 years (range, 12.2-32.5 years), with 49% females. Mean 131I thyroid dose was 0.79 Gy (range, 0-40.7 Gy). There were 719 cases with hypothyroidism (TSH > 4 mIU/L), including 14 with overt hypothyroidism. We found a significant, small association between (131)I thyroid doses and prevalent hypothyroidism, with the excess odds ratio (EOR) per gray of 0.10 (95% confidence interval, 0.03-0.21). EOR per gray was higher in individuals with ATPO < or = 60 U/mL compared with individuals with ATPO > 60 U/mL (p < 0.001). CONCLUSIONS: This is the first study to find a significant relationship between prevalence of hypothyroidism and individual (131)I thyroid doses due to environmental exposure. The radiation increase in hypothyroidism was small (10% per Gy) and limited largely to subclinical hypothyroidism. Prospective data are needed to evaluate the dynamics of radiation-related hypothyroidism and clarify the role of antithyroid antibodies.
机译:背景:甲状腺功能减退症是接受高剂量碘131(131I)治疗的患者中最常见的甲状腺异常。从低至中度131I甲状腺剂量进行甲状腺功能减退的风险数据有限且不一致。目的:进行这项研究的目的是量化与因霍诺贝利事故而接受的131I剂量有关的甲减患病风险。方法:这是一项对横断面(1998-2000年)甲状腺疾病的筛查研究,研究对象为事故发生时11853名年龄在18岁以下的人群,并在事故发生后2个月内进行了个体甲状腺放射性测量。我们测量了血清中的促甲状腺激素(TSH),游离甲状腺素和甲状腺过氧化物酶(ATPO)抗体。结果:分析队列的平均年龄为21.6岁(范围12.2-32.5岁),女性为49%。 131I甲状腺平均剂量为0.79 Gy(范围为0-40.7 Gy)。共有719例甲减(TSH> 4 mIU / L),包括14例甲减。我们发现(131)I甲状腺剂量与普遍的甲状腺功能减退之间存在显着的小关联,每灰阶的比值比(EOR)为0.10(95%置信区间0.03-0.21)。与ATPO> 60 U / mL的个体相比,ATPO <60 U / mL的个体的每灰色EOR更高(p <0.001)。结论:这是第一个发现甲状腺功能减退症患病率与由于环境暴露引起的个体(131)I甲状腺剂量之间显着相关的研究。甲状腺功能减退症的放射增幅很小(每Gy 10%),并且主要限于亚临床甲状腺功能减退症。需要前瞻性数据来评估与放射有关的甲状腺功能减退症的动力学,并阐明抗甲状腺抗体的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号